Show simple item record

dc.contributor.authorvon Grabowiecki, Y.
dc.contributor.authorPhatak, V.
dc.contributor.authorAschauer, L.
dc.contributor.authorMuller, P. A. J.
dc.date.accessioned2022-01-31T15:49:10Z
dc.date.available2022-01-31T15:49:10Z
dc.date.issued2021en
dc.identifier.citationvon Grabowiecki Y, Phatak V, Aschauer L, Muller PAJ. Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in Cancer. Frontiers in Oncology. 2021;11:8.en
dc.identifier.doi10.3389/fonc.2021.804107en
dc.identifier.urihttp://hdl.handle.net/10541/625035
dc.description.abstractRab11-FIP1 is a Rab effector protein that is involved in endosomal recycling and trafficking of various molecules throughout the endocytic compartments of the cell. The consequence of this can be increased secretion or increased membrane expression of those molecules. In general, expression of Rab11-FIP1 coincides with more tumourigenic and metastatic cell behaviour. Rab11-FIP1 can work in concert with oncogenes such as mutant p53, but has also been speculated to be an oncogene in its own right. In this perspective, we will discuss and speculate upon our observations that mutant p53 promotes Rab11-FIP1 function to not only promote invasive behaviour, but also chemoresistance by regulating a multitude of different proteins.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.3389/fonc.2021.804107en
dc.titleRab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in Canceren
dc.typeArticleen
dc.contributor.departmentTumour Suppressors Group, Cancer Research United Kingdom (UK) Manchester Institute, The University of Manchester, Macclesfield, United Kingdomen
dc.identifier.journalFrontiers in Oncologyen
dc.description.noteen]
refterms.dateFOA2022-04-19T12:38:17Z


Files in this item

Thumbnail
Name:
Rab11.pdf
Size:
2.961Mb
Format:
PDF
Description:
From CORE

This item appears in the following Collection(s)

Show simple item record